A method for the removal of platelet aggregating activity of commercial apyrase.
D001081:Apyrase / Q000302:isolation & purification / Q000494:pharmacology*; D002846:Chromatography, Affinity; D004340:Drug Contamination; D006801:Humans; D037102:Lectins; D010744:Phosphoric Monoester Hydrolases / Q000494:pharmacology*; D010974:Platelet Aggregation / Q000187:drug effects*
D037102:Lectins; D010744:Phosphoric Monoester Hydrolases; D001081:Apyrase